Bookmark and Share

Neuroethics

Edited by L. Syd M Johnson (Michigan Technological University)
About this topic
Summary Neuroethics is a nascent subdiscipline that has emerged out of bioethics and neuroscience to consider the ethical issued raised by developments in neuroscience, particularly recent developments in neuroetechnologies. The scope of neuroethics is broad and heterogeneous. In her seminal 2002 paper, philosopher and neuroscientist Adina Roskies bisected the field of neuroethics into two broad sectors: the ethics of neuroscience, and the neuroscience of ethics. The ethics of neuroscience overlaps significantly with traditional issues in biomedical ethics, including the ethics of neuroscientific research, and the ethical, legal, and social implications of new developments and discoveries in neuroscience. The “neuroscience of ethics”  engages with traditional ethical questions, and (controversially) overlaps with neurophilosophical, metaphysical inquiries concerning free will and personal identity as they inform and interact with important ethical and social issues. Specific areas of neuroethical interest include: cognitive enhancement, disorders of consciousness and neurological impairment, psychiatric disorders, brain imaging, free will/moral responsibility, and addiction, and the neuroscientific study of morality and decision-making.
Key works The broad scope of neuroethics defies a concise bibliography. Moreover, while there is overlap in some foci of neuroethics, there are also regions that stand apart. This article reflects neuroethics' origins as a subdiscipline of bioethics by examining ethical issues in clinical neuroscience (Glannon 2011). The moral significance of consciousness (Kahane & Savulescu 2009), and the role of neuroscience in illuminating the "problem of other minds" with respect to brain damage, and nonhuman animals (Farah 2008) is a subject with an extensive literature. Works on issues related to control, responsibility, freedom, and addiction include Hall 2003 and Glannon 2013Persson & Savulescu 2008 proposes both cognitive and moral enhancement. The neuroscience of ethics overlaps considerably with the work of experimental philosophers, e.g. Knobe 2003Greene unknown, and Appiah 2008.
Introductions For a general introductions to neuroethics, see Illes & Sahakian 2011 and Levy 2009 and Roskies 2002.
  Show all references
Related categories
Subcategories:See also:
1036 found
Search inside:
(import / add options)   Sort by:
1 — 50 / 1036
Material to categorize
  1. N. Agar (2014). A Question About Defining Moral Bioenhancement. Journal of Medical Ethics 40 (6):369-370.
    David DeGrazia1 offers, to my mind, a decisive response to the bioconservative suggestion that moral bioenhancement threatens human freedom or undermines its value. In this brief commentary, I take issue with DeGrazia's way of defining MB. A different concept of MB exposes a danger missed by his analysis.Two ways to define MBDeGrazia presents MB as a form of enhancement directed at moral capacities. There are, in the philosophical literature, two broad approaches to defining human enhancement. Simplifying somewhat, one account identifies (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  2. Elisabeth Ahlsén (2008). Neurological Disorders of Embodied Feedback. In Ipke Wachsmuth, Manuela Lenzen & Günther Knoblich (eds.), Embodied Communication in Humans and Machines. Oup Oxford.
  3. Wael K. Al-Delaimy (2012). Ethical Concepts and Future Challenges of Neuroimaging: An Islamic Perspective. Science and Engineering Ethics 18 (3):509-518.
    Neuroscience is advancing at a rapid pace, with new technologies and approaches that are creating ethical challenges not easily addressed by current ethical frameworks and guidelines. One fascinating technology is neuroimaging, especially functional Magnetic Resonance Imaging (fMRI). Although still in its infancy, fMRI is breaking new ground in neuroscience, potentially offering increased understanding of brain function. Different populations and faith traditions will likely have different reactions to these new technologies and the ethical challenges they bring with them. Muslims are approximately (...)
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  4. Roberto Andorno (2012). Do Our Moral Judgments Need to Be Guided by Principles? Cambridge Quarterly of Healthcare Ethics 21 (04):457-465.
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  5. A. Antonini, R. Benti, R. Notaris, S. Tesei, A. Zecchinelli, G. Sacilotto, N. Meucci, M. Canesi, C. Mariani, G. Pezzoli & P. Gerundini (2003). 123i-Ioflupane/Spect Binding to Striatal Dopamine Transporter (Dat) Uptake in Patients with Parkinson's Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy. Neurological Sciences 24 (3).
    Remove from this list |
    Translate to English
    | Direct download  
     
    My bibliography  
     
    Export citation  
  6. Rothenberger Aribert, Roessner Veit & Banaschewski Tobias (2006). Habit Formation in Tourette Syndrome with Associated Obsessive-Compulsive Behavior: At the Crossroads of Neurobiological Modelling. Behavioral and Brain Sciences 29 (6).
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  7. M. Ángeles Arráez, Miguel Moreno, Francisco Lara, Pedro Francés & Javier Rodríguez Alcázar (2010). Bioethics and Human Enhancement: An Interview with Julian Savulescu. Dilemata 3:15-25.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  8. Yubraj Aryal (2010). On the Death of Human and Its History. Journal of Philosophy: A Cross-Disciplinary Inquiry 5 (11):1-8.
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  9. T. Z. Aziz & J. F. Stein (2004). Brain Stimulation. In R. L. Gregory (ed.), The Oxford Companion to the Mind. Oxford University Press. 129--136.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  10. Kathleen E. Bachynski & Daniel S. Goldberg (2014). Youth Sports & Public Health: Framing Risks of Mild Traumatic Brain Injury in American Football and Ice Hockey. Journal of Law, Medicine and Ethics 42 (3):323-333.
    The framing of the risks of experiencing mild traumatic brain injury in American football and ice hockey has an enormous impact in defining the scope of the problem and the remedies that are prioritized. According to the prevailing risk frame, an acceptable level of safety can be maintained in these contact sports through the application of technology, rule changes, and laws. An alternative frame acknowledging that these sports carry significant risks would produce very different ethical, political, and social debates.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  11. Jing Bai & Renzong Qiu (2014). Some Issues in Neuroethics. In Akira Akabayashi (ed.), The Future of Bioethics: International Dialogues. Oup Oxford. 65.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  12. Jodie A. Baird (2005). Is There a “Social Brain”? In B. Malle & S. Hodges (eds.), Other Minds. Guilford Press. 75.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  13. Giampiero Bambagioni (2012). On the Valorisation of Public Real Estate Enhancement: The Valuation of Programs and Projects (Feasibility Study). Techne: Journal of Technology for Architecture and Environment 3.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  14. Roger A. Barker (2006). Neural Transplants for Parkinson's Disease: What Are the Issues? Poiesis and Praxis 4 (2):129-143.
    Parkinson’s disease (PD) is a common neurodegenerative disorder of the nervous system that affects about 1 in 800 people and for which we have symptomatic but not curative therapies. At the core of the disease is the loss of a specific population of dopaminergic neurons within the brain, and replacement of dopamine through drug therapies has provided clinically significant benefit for many patients. However this therapy only ever offers a temporary amelioration of symptoms and with time this symptomatic therapy becomes (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  15. Simon Baron-Cohen, Helen Tager-Flusberg & Donald J. Cohen (2000). Understanding Other Minds Perspectives From Developmental Cognitive Neuroscience. Monograph Collection (Matt - Pseudo).
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  16. Victoria Bates (2012). 'Misery Loves Company': Sexual Trauma, Psychoanalysis and the Market for Misery. [REVIEW] Journal of Medical Humanities 33 (2):61-81.
    This article examines sexual ‘misery memoirs’, focusing on author/reader and genre/market relationships in the context of models of trauma and child sexual abuse. It shows that the success of sexual ‘misery memoirs’ is inextricably bound up with the popular dissemination of a feminist-psychoanalytic model of traumatic memory that has taken place since the 1970s. It also argues that, as the ‘truth’ of recovered and traumatic memories has been fundamental to its success, anxieties about false memory and hoax ‘misery memoirs’ have (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  17. Christine M. Baugh, Emily Kroshus, Alexandra P. Bourlas & Kaitlyn I. Perry (2014). Requiring Athletes to Acknowledge Receipt of Concussion‐Related Information and Responsibility to Report Symptoms: A Study of the Prevalence, Variation, and Possible Improvements. Journal of Law, Medicine and Ethics 42 (3):297-313.
    State concussion laws and sport-league policies are important tools for protecting public health, but also present implementation challenges. Both state laws and league policies often require athletes provide written acknowledgement of having received concussion-related information and/or of their responsibility to report concussion-related symptoms. This paper examines these requirements in two ways: an analysis of the variation in state laws and sport-league policies and a study of their effects in a cohort of collegiate football players.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  18. Kurt Bayertz, Birgit Beck & Barbara Stroop (2012). C Literaturberichte-Künstliches Glück? Biotechnisches Enhancement als (vermeintliche) Abkürzung zum guten Leben. Philosophischer Literaturanzeiger 65 (4).
    Remove from this list |
    Translate to English
    |
     
    My bibliography  
     
    Export citation  
  19. William W. Beatty & Nancy Monson (1989). Geographical Knowledge in Patients with Parkinson's Disease. Bulletin of the Psychonomic Society 27 (5):473-475.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  20. Bruce M. Becker & Larry D. Reid (1977). Daily L-Δ9-Tetrahydrocannabinol and Pressing for Hypothalamic Stimulation. Bulletin of the Psychonomic Society 10 (4):325-327.
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  21. Emily Bell, Bruce Maxwell, Mary Pat McAndrews, Abbas Sadikot & Eric Racine (2010). Hope and Patients' Expectations in Deep Brain Stimulation: Healthcare Providers' Perspectives and Approaches. Journal of Clinical Ethics 21 (2):112.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  22. Emily Bell & Eric Racine (2010). Deep Brain Stimulation, Ethics, and Society. Journal of Clinical Ethics 21 (2):101.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  23. Martin Benjamin (forthcoming). Pragmatism and the Determination of Death. Pragmatic Bioethics:193--206.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  24. Ron Berghmans, Ruud ter Meulen, Andrea Malizia & Rein Vos (2011). In Mood Enhancement. In Guy Kahane, Julian Savulescu & Ruud Ter Meulen (eds.), Enhancing Human Capacities.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  25. Ferenc Biedermann (2010). Argumente für und wider das Cognitive Enhancement. Ethik in der Medizin 22 (4):317-329.
    Das Cognitive Enhancement, die Steigerung der geistigen Leistungsfähigkeit gesunder Menschen durch Psychopharmaka und andere Interventionen, ist in jüngster Zeit verstärkt in den Fokus sowohl der Ethik als auch der breiteren Öffentlichkeit geraten. In kontrafaktischer Abstrahierung vom gegenwärtig noch sehr bescheidenen Stand der Technik wird dabei unter anderem erörtert, was grundsätzlich für und was gegen den Einsatz von markant wirksamem Cognitive Enhancement sprechen würde. Der vorliegende Beitrag gibt einen Überblick über die einschlägige Diskussion. Zunächst wird der recht uneinheitlich verwendete Begriff des (...)
    Remove from this list |
    Translate to English
    | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  26. Ferenc Biedermann (2010). Arguments in Favour of and Against Cognitive Enhancement A Critical Survey. Ethik in der Medizin 22 (4):317-329.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  27. Par A. Bjorkstrand (1973). Electrodermal Responses as Affected by Subject- Versus Experimenter-Controlled Noxious Stimulation. Journal of Experimental Psychology 97 (3):365.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  28. E. Bleuler (2005). Dementia Praecox, or the Group of Schizophrenias. Translater by J. Zinkin (1950). New York: International Universities. Cited By: Bachman, P. & Cannon, TD. Cognitive and Neuroscience Aspects of Thought Disorders. [REVIEW] In K. Holyoak & B. Morrison (eds.), The Cambridge Handbook of Thinking and Reasoning. Cambridge Univ Pr. 493--519.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  29. G. Bognar (2012). Human Enhancement, Edited by Julian Savulescu and Nick Bostrom. Mind 121 (481):225-229.
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  30. Dr Phil Joachim Boldt & Uta Bittner (2013). Gedächtnis-Enhancement. Wie erstrebenswert wäre ein grenzenloses Gedächtnis? Ethik in der Medizin 25 (4):315-328.
    Gedächtnis-Enhancement oder Memory-Enhancement ist ein Teilbereich der verschiedenen Ansätze zur pharmakologischen und technischen Verbesserung menschlicher Leistungsfähigkeit. Wie Erfahrungsberichte von Menschen mit von Natur aus gesteigertem Erinnerungsvermögen zeigen, ist eine Steigerung der Gedächtnisfähigkeit prinzipiell möglich. Allerdings verweisen diese Erfahrungen auch auf einige Komplikationen und Beschwernisse infolge dieser gesteigerten Leistungsfähigkeit. Es wird argumentiert, dass erstens diejenigen philosophischen Theorien, die die Funktion des Gedächtnisses v. a. in der Speicherung von Informationen lokalisieren, einige dieser Probleme nicht antizipieren und nur unzulänglich erklären können. Zweitens wird (...)
    Remove from this list |
    Translate to English
    | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  31. Joachim Boldt & Uta Bittner (2013). Gedächtnis-Enhancement. Wie erstrebenswert wäre ein grenzenloses Gedächtnis? Ethik in der Medizin 25 (4):315-328.
    Remove from this list |
    Translate to English
    | Direct download  
     
    My bibliography  
     
    Export citation  
  32. L. L. E. Bolt (2007). True to Oneself? Broad and Narrow Ideas on Authenticity in the Enhancement Debate. Theoretical Medicine and Bioethics 28 (4):285-300.
    Our knowledge of the human brain and the influence of pharmacological substances on human mental functioning is expanding. This creates new possibilities to enhance personality and character traits. Psychopharmacological enhancers, as well as other enhancement technologies, raise moral questions concerning the boundary between clinical therapy and enhancement, risks and safety, coercion and justice. Other moral questions include the meaning and value of identity and authenticity, the role of happiness for a good life, or the perceived threats to humanity. Identity and (...)
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  33. Emily Borgelt, James A. Anderson & Judy Illes (2013). Managing Incidental Findings: Lessons From Neuroimaging. American Journal of Bioethics 13 (2):46 - 47.
    Remove from this list | Direct download (3 more)  
     
    My bibliography  
     
    Export citation  
  34. B. Boshes (1969). Syndromes of the Diencephalon. In P. Vinken & G. Bruyn (eds.), Handbook of Clinical Neurology. North Holland. 2--432.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  35. Rebecca Brashler (2004). The Trauma of Discharge Planning Following Brain Injury. Journal of Clinical Ethics 15 (4):314.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  36. Peter R. Breggin (1990). Brain Damage, Dementia, and Persistent Cognitive Dysfunction Associated with Neuroleptic Drugs: Evidence, Etiology, Implications. Journal of Mind and Behavior 11 (3):4.
    Several million people are treated with neuroleptic medications in North America each year. A large percentage of these patients develop a chronic neurologic disorder-tardive dyskinesia-characterized by abnormal movements of the voluntary muscles. Most cases are permanent and there is no known treatment. Evidence has been accumulating that the neuroleptics also cause damage to the highest centers of the brain, producing chronic mental dysfunction, tardive dementia and tardive psychosis. These drug effects may be considered a mental equivalent of tardive dyskinesia. Relevant (...)
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  37. C. D. Brewer & Heather DeGrote (2013). Regulating Methylphenidate: Enhancing Cognition and Social Inequality. American Journal of Bioethics 13 (7):47-49.
    Remove from this list | Direct download (4 more)  
     
    My bibliography  
     
    Export citation  
  38. Hillel Broder (2013). Lisa M. Hermsen, Manic Minds: Mania's Mad History and Its Neuro-Future. [REVIEW] Journal of Medical Humanities 34 (1):81-84.
    Remove from this list | Direct download (6 more)  
     
    My bibliography  
     
    Export citation  
  39. Eduardo Bruera (forthcoming). Severe Organic Brain Syndrome. Journal of Palliative Care.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  40. Bengt Brülde (2007). Can Successful Mood Enhancement Make Us Less Happy? Philosophica 79:39-56.
    The main question is whether chemically induced mood enhancement is (if successful) likely to make us happier, or whether it may rather have detrimental effects on our long-term happiness. This question is divided into three: (i) What effects are mood-enhancing drugs likely to have on the long-term happiness of the person who takes these drugs? (ii) How would these drugs affect the happiness of the immediate environment of the people who take them, e.g. children or spouses? (iii) What effects would (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  41. R. L. Buckner & D. C. Carroll (2007). Self-Projection and the Brain. Trends in Cognitive Sciences 11 (2):49-57.
    Remove from this list | Direct download (5 more)  
     
    My bibliography  
     
    Export citation  
  42. T. Buller (forthcoming). Editorial: What Can Neuroscience Contribute to Ethics? Journal of Medical Ethics.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  43. Roberto Cabeza, Elisa Ciaramelli & Morris Moscovitch (2012). Cognitive Contributions of the Ventral Parietal Cortex: An Integrative Theoretical Account. Trends in Cognitive Sciences 16 (6):338-352.
    Remove from this list | Direct download (9 more)  
     
    My bibliography  
     
    Export citation  
  44. Laura Y. Cabrera, Nicholas S. Fitz & Peter B. Reiner (forthcoming). Empirical Support for the Moral Salience of the Therapy-Enhancement Distinction in the Debate Over Cognitive, Affective and Social Enhancement. Neuroethics:1-14.
    The ambiguity regarding whether a given intervention is perceived as enhancement or as therapy might contribute to the angst that the public expresses with respect to endorsement of enhancement. We set out to develop empirical data that explored this. We used Amazon Mechanical Turk to recruit participants from Canada and the United States. Each individual was randomly assigned to read one vignette describing the use of a pill to enhance one of 12 cognitive, affective or social domains. The vignettes described (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  45. Laura Y. Cabrera, Nicholas S. Fitz & Peter B. Reiner (forthcoming). Reasons for Comfort and Discomfort with Pharmacological Enhancement of Cognitive, Affective, and Social Domains. Neuroethics:1-14.
    The debate over the propriety of cognitive enhancement evokes both enthusiasm and worry. To gain further insight into the reasons that people may have for endorsing or eschewing pharmacological enhancement , we used empirical tools to explore public attitudes towards PE of twelve cognitive, affective, and social domains . Participants from Canada and the United States were recruited using Mechanical Turk and were randomly assigned to read one vignette that described an individual who uses a pill to enhance a single (...)
    Remove from this list | Direct download (2 more)  
     
    My bibliography  
     
    Export citation  
  46. Ld Cahan, Gb Hieshima, Rt Higashida & Vv Halbach (1988). Use of Intraoperative Angiography in Neurosurgery. Journal of Mind and Behavior 9 (3):289-297.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  47. V. Cakic (2009). Smart Drugs for Cognitive Enhancement: Ethical and Pragmatic Considerations in the Era of Cosmetic Neurology. Journal of Medical Ethics 35 (10):611-615.
    Reports in the popular press suggest that smart drugs or “nootropics” such as methylphenidate, modafinil and piracetam are increasingly being used by the healthy to augment cognitive ability. Although current nootropics offer only modest improvements in cognitive performance, it appears likely that more effective compounds will be developed in the future and that their off-label use will increase. One sphere in which the use of these drugs may be commonplace is by healthy students within academia. This article reviews the ethical (...)
    Remove from this list | Direct download (9 more)  
     
    My bibliography  
     
    Export citation  
  48. Turhan Canli (2005). When Genes and Brains Unite: Ethical Implications of Genomic Neuroimaging. In Judy Illes (ed.), Neuroethics: Defining the Issues in Theory, Practice, and Policy. Oup Oxford.
    Remove from this list |
     
    My bibliography  
     
    Export citation  
  49. B. J. Casey, Nim Tottenham, Conor Liston & Sarah Durston (2005). Magnetic Resonance Methods. Trends in Cognitive Sciences 9 (3):104-110.
    Remove from this list | Direct download  
     
    My bibliography  
     
    Export citation  
  50. F. Xavier Castellanos & Erika Proal (2012). Large-Scale Brain Systems in ADHD: Beyond the Prefrontal–Striatal Model. Trends in Cognitive Sciences 16 (1):17-26.
    Remove from this list | Direct download (9 more)  
     
    My bibliography  
     
    Export citation  
1 — 50 / 1036